Solventum Corporation (SOLV) Total Return CAGR:6.47%(TTM)
Over the latest trailing 12-month period, Solventum Corporation (SOLV)'s total return cagr is +6.47%. The comparable SPY value is +22.75%. Year-to-date total return is -0.03%. Total return includes price appreciation and reinvested dividends.
Over the past 12 months, Solventum Corporation's Total Return CAGR is 6.47%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Solventum Corporation's investment performance.
SOLV Total Return CAGR Chart
Solventum Corporation (SOLV)
SOLV Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 6 quarters.
SOLV Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 99.05 | 99.03 | -0.02 | -0.03% | -0.03% |
| 2025 | 82.58 | 99.05 | +16.47 | +19.95% | +19.95% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 99 | +21.3% | +4.5% |
| Q1 2026 | 82 | -17.6% | -14.1% |
| Q4 2025 | 99 | +8.5% | +20.0% |
| Q3 2025 | 91 | -3.7% | +4.7% |
| Q2 2025 | 95 | -0.3% | +43.4% |
| Q1 2025 | 95 | +15.1% | +9.3% |
| Q4 2024 | 83 | -5.2% | — |
| Q3 2024 | 87 | +31.8% | — |
| Q2 2024 | 66 | -24.0% | — |
| Q1 2024 | 87 | — | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson